...
首页> 外文期刊>European Journal of Radiology >Outcome of uterine artery embolization versus MR-guidedhigh-intensity focused ultrasound treatment for uterine fibroids:Long-term results
【24h】

Outcome of uterine artery embolization versus MR-guidedhigh-intensity focused ultrasound treatment for uterine fibroids:Long-term results

机译:子宫动脉栓塞与MR引导的高强度聚焦超声治疗子宫肌瘤的结果:长期结果

获取原文
获取原文并翻译 | 示例

摘要

Objectives: To compare the long-term outcome after uterine artery embolization (UAE) versus magneticresonance-guided high-intensity focused ultrasound (MR-g HIFU) for symptomatic uterine fibroids.Methods: Seventy-seven women (median age, 39.3 years; range, 29.2-52.2 years) with symptomatic uter-ine fibroids, equally eligible for UAE and MR-g HIFU based on our exclusion criteria underwent treatment(UAE, N = 41; MR-g HIFU, N = 36) from 2002 to 2009 at our institution. Symptom severity (SS) and totalhealth-related quality of life (Total HRQoL) scores were assessed by the uterine fibroid symptom andquality of life (UFS-QoL) questionnaire before treatment and at long-term follow-up after UAE (median61.9 months) and after MR-g HIFU (median: 60.7 months). Re-intervention rates were assessed for eachtherapy and compared.Results: Re-intervention was significantly lower after UAE (12.2%) than after MR-g HIFU (66.7%) at long-term follow-up (p < 0.001). After UAE changes in SS (50 pre-treatment vs. 6.3 post-treatment) and TotalHRQoL (57.8 pre-treatment vs. 100 post-treatment) were significantly better than changes in SS (42.2 pre-treatment vs. 26.6 post-treatment) and Total HRQoL score (66.4 pre-treatment vs. 87.9 post-treatment)after MR-g HIFU (p = 0.019 and 0.049 respectively).Conclusions: Improvement of SS and Total HRQoL scores was significantly better after UAE resulting in asignificant lower re-intervention rate compared to MR-g HIFU.
机译:目的:比较有症状的子宫肌瘤的子宫动脉栓塞术(UAE)与磁共振引导的高强度聚焦超声检查(MR-g HIFU)的长期结果。方法:77名女性(中位年龄,39.3岁;范围) ,有症状的子宫肌瘤(29.2-52.2岁),根据我们的排除标准,同样有资格接受阿联酋和MR-g HIFU的治疗(UAE,N = 41; MR-g HIFU,N = 36),时间为2002年至2009年我们的机构。在治疗前和接受阿联酋治疗后的长期随访中,通过子宫肌瘤症状和生活质量(UFS-QoL)问卷评估了症状严重程度(SS)和与总健康相关的生活质量(总HRQoL)评分(中位数61.9个月) )和MR-g HIFU之后(中位数:60.7个月)。结果:在长期随访中,UAE(12.2%)后的再干预率显着低于MR-g HIFU(66.7%)后的再干预率(p <0.001)。在阿联酋之后,SS的变化(治疗前为50,治疗后为6.3)和TotalHRQoL(治疗前的57.8,后为100)明显好于SS的变化(治疗前为42.2,治疗后为26.6)。和MR-g HIFU后总HRQoL评分(治疗前为66.4,治疗后为87.9)(分别为p = 0.019和0.049)。干预率与MR-g HIFU相比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号